Edgewise Therapeutics
EWTX
EWTX
90 hedge funds and large institutions have $594M invested in Edgewise Therapeutics in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 94 → 90 (-4)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
50% less call options, than puts
Call options by funds: $25K | Put options by funds: $50K
Holders
90
Holding in Top 10
3
Calls
$25K
Puts
$50K
Top Buyers
| 1 | +$8.96M | |
| 2 | +$6.78M | |
| 3 | +$5.47M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.07M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.78M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$2.99M | |
| 3 | -$1.61M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.21M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.09M |